Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

News Conference News AHA 2025

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

Todd Neale

November 14, 2025

News Features

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Michael O'Riordan

September 17, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Daily News

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Caitlin E. Cox

March 07, 2024

News Daily News

Experts Warn of Looming Private Equity Interest in Cardiology Care

Michael O'Riordan

January 15, 2024

News Conference News AHA 2023

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

Caitlin E. Cox

November 14, 2023

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

News Daily News

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

L.A. McKeown

August 31, 2023

News Features

As US Abortion Access Grows Patchier, Cardiologist Concerns Mount

Todd Neale

May 15, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Daily News

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

Shelley Wood

August 15, 2022

News Daily News

‘It’s All Cuts’: Cardiologists React to the 2023 CMS Proposed Rule

Yael L. Maxwell

July 15, 2022

News Daily News

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

L.A. McKeown

June 21, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

One in Six HF Patients Delay or Forego Care, Inflating Costs

Shelley Wood

August 12, 2021

Advertisement

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

January 2025 Dispatch for the CV Team

AHA Statement Outlines Cardiac Contributions to Brain Health

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Physicians (Mostly) Negative on Private Equity in Healthcare

How Meaningful Are Heart Failure Hospitalizations in Today’s RCTs?

Experts Warn of Looming Private Equity Interest in Cardiology Care

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

As US Abortion Access Grows Patchier, Cardiologist Concerns Mount

Vast Majority of HFrEF Patients Eligible for Vericiguat

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

‘It’s All Cuts’: Cardiologists React to the 2023 CMS Proposed Rule

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

Dapagliflozin Boosts Health Status Across LVEF Range

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

One in Six HF Patients Delay or Forego Care, Inflating Costs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content